Hostname: page-component-7479d7b7d-c9gpj Total loading time: 0 Render date: 2024-07-12T11:20:59.987Z Has data issue: false hasContentIssue false
  • English
  • Français

Unusual presentation of mitral prosthetic heart valve thrombosis managed with low dose tenecteplase infusion

Published online by Cambridge University Press:  04 March 2021

A. Shaheer Ahmed Open the ORCID record for A. Shaheer Ahmed [Opens in a new window]  and
Shivank Gupta
A. Shaheer Ahmed*
Affiliation:
Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
Shivank Gupta
Affiliation:
Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
*
Author for correspondence: Dr. A. Shaheer Ahmed MD, DM, DNB, Assistant Professor, Department of Cardiology, 7th Floor, Super Speciality Block, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi110029, India. Phone: +919968889874. E-mail: ahmedshaheer53@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

A 11-year-old with history of mitral valve replacement presented with low-grade fever, breathlessness and multiple episodes of haemoptysis for 2 days. Detailed echocardiographic evaluation revealed possible prosthetic valve thrombosis, which was confirmed by fluoroscopy. She was thrombolysed with low dose infusion of tenecteplase. Post thrombolysis her symptoms improved, valve mobility was restored, and haemoptysis subsided. Left sided prosthetic valve thrombosis presenting predominantly with haemoptysis is very rare.

Keywords

Prosthetic heart valve thrombosistenecteplasehaemoptysis
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 8 , August 2021 , pp. 1353 - 1355
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roudaut, R, Serri, K, Lafitte, S Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart Br Card Soc 2007; 93: 137–142.CrossRefGoogle ScholarPubMed
Talwar, S, Kapoor, CK, Velayoudam, D, et al. Anticoagulation protocol and early prosthetic valve thrombosis. Indian Heart J 2004; 56: 225–228.Google ScholarPubMed
Zoghbi, WA, Chambers, JB, Dumesnil, JG, et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography’s Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2009; 22: 975–1014; quiz 1082–4.10.1016/j.echo.2009.07.013CrossRefGoogle Scholar
Baumgartner, H, Falk, V, Bax, JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739–2791.10.1093/eurheartj/ehx391CrossRefGoogle ScholarPubMed
Kumar Jha, R, Bansal, S, Issar, HS, et al. Treatment of prosthetic valve thrombosis with bolus dose tenecteplase: an experience from a developing country. J Heart Valve Dis 2017; 26: 349–354.Google ScholarPubMed
Sharma, V, Singh, R, Mishra, R, et al. Use of tenecteplase for left-sided prosthetic valve thrombosis. J Assoc Physicians India 2012; 60: 55–58.Google ScholarPubMed
Kathirvel, D, Justin Paul, G, Prathap Kumar, G, et al. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis. Indian Heart J 2018; 70: 506–510.CrossRefGoogle ScholarPubMed
Özkan, M, Gündüz, S, Gürsoy, OM, et al. Ultraslow thrombolytic therapy: a novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: the Ultra-slow PROMETEE trial. Am Heart J 2015; 170: 409–418.10.1016/j.ahj.2015.04.025CrossRefGoogle ScholarPubMed
Özkan, M, Gündüz, S, Biteker, M, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging 2013; 6: 206–216.10.1016/j.jcmg.2012.10.016CrossRefGoogle ScholarPubMed

Ahmed and Gupta supplementary material

Ahmed and Gupta supplementary material 1

Download Ahmed and Gupta supplementary material(Audio)
Audio 2 MB

Ahmed and Gupta supplementary material

Ahmed and Gupta supplementary material 2

Download Ahmed and Gupta supplementary material(Audio)
Audio 1.8 MB